Profound Medical elevates the predictability of prostate cancer treatment through its MR-enabled therapeutic ultrasound platform, designed to standardise planning, targeting and ablation within a single, integrated workflow. This fusion of imaging and therapy gives clinicians unparalleled control, improving consistency across complex cases.​ ​ With Transmedic bringing Profound Medical to centres across Southeast Asia, oncology teams gain access to a next-generation modality that enhances precision and operational efficiency.